Analyst Consensus ?
ConsensusBuy37 ratings
Bullish2567.6%
Neutral1129.7%
Bearish12.7%
FN2 Earnings Intelligence
Merck & Co., Inc. analyst ratings
Merck & Co., Inc. (MRK) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$144.71Previous close
$80Low
$135.49Average
$180High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Leerink Partners | Outperform | Outperform | Maintain | Sep 9, 2026 |
| Guggenheim | Buy | Buy | Maintain | Sep 8, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 4, 2026 |
| Wolfe Research | Outperform | Outperform | Maintain | Aug 25, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 25, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Aug 21, 2026 |
| UBS | Buy | Buy | Maintain | Aug 20, 2026 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Aug 20, 2026 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Aug 20, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 20, 2026 |
| Daiwa Capital | Outperform | Neutral | Upgrade | Aug 12, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 13, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 6, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Jun 30, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 30, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Mar 20, 2026 |
| Freedom Broker | Hold | Hold | Maintain | Feb 9, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jan 20, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Nov 18, 2025 |
| Berenberg | Hold | Buy | Downgrade | Sep 17, 2025 |
| Truist Securities | Hold | Buy | Downgrade | Jan 8, 2025 |
| Societe Generale | Sell | Hold | Downgrade | Mar 11, 2024 |
| Atlantic Equities | Overweight | Overweight | Maintain | May 1, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Mar 7, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Feb 3, 2023 |
| Erste Group | Buy | Hold | Upgrade | Aug 25, 2022 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Jun 27, 2022 |
| Bank of America | Buy | Buy | Maintain | May 1, 2019 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Oct 29, 2018 |
| DZ Bank | Buy | Hold | Upgrade | Feb 13, 2018 |
| Leerink Swann | Market Perform | Market Perform | Maintain | Feb 6, 2018 |
| Jefferies | Hold | Underperform | Upgrade | Oct 31, 2017 |
| Bernstein | Outperform | Market Perform | Upgrade | Jan 5, 2015 |
| MainFirst Bank AG | Outperform | Underperform | Upgrade | Jul 28, 2014 |
| Mainfirst | Outperform | Underperform | Upgrade | Jul 28, 2014 |
| MKM Partners | Buy | Buy | Maintain | Apr 14, 2014 |
Named analyst price targets
Upside is calculated against the persisted previous close $144.71. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| HSBC | Analyst unavailable | $172 | $147.6 | +18.9% | Sep 10, 2026 |
| Leerink Partners | Analyst unavailable | $161 | $148.49 | +11.3% | Sep 9, 2026 |
| Guggenheim | Vamil Divan | $170 | $150.34 | +17.5% | Sep 8, 2026 |
| Wells Fargo | Analyst unavailable | $170 | $152.34 | +17.5% | Sep 4, 2026 |
| Argus Research | Jasper Hellweg | $170 | $153.61 | +17.5% | Aug 25, 2026 |
| Wolfe Research | Alexandria Hammond | $180 | $150.69 | +24.4% | Aug 25, 2026 |
| Goldman Sachs | Analyst unavailable | $160 | $149.25 | +10.6% | Aug 21, 2026 |
| BMO Capital | Analyst unavailable | $170 | $149.65 | +17.5% | Aug 20, 2026 |
| UBS | Analyst unavailable | $175 | $152.22 | +20.9% | Aug 20, 2026 |
| RBC Capital | Analyst unavailable | $150 | $152.22 | +3.7% | Aug 20, 2026 |
| UBS | Matthew Weston | $150 | $152.22 | +3.7% | Aug 20, 2026 |
| Morgan Stanley | Analyst unavailable | $179 | $152.22 | +23.7% | Aug 19, 2026 |
| Daiwa | Analyst unavailable | $143 | $130.45 | -1.2% | Aug 12, 2026 |
| Argus Research | Jasper Hellweg | $145 | $130.9 | +0.2% | Aug 11, 2026 |
| Morgan Stanley | Terence Flynn | $116 | $130.4 | -19.8% | Aug 5, 2026 |
| Guggenheim | Vamil Divan | $146 | $128.04 | +0.9% | Aug 5, 2026 |
| Barclays | Emily Field | $150 | $131.84 | +3.7% | Jul 29, 2026 |
| Bernstein | Courtney Breen | $105 | $132.34 | -27.4% | Jul 27, 2026 |
| BMO Capital | Analyst unavailable | $142 | $124.08 | -1.9% | Jul 13, 2026 |
| Guggenheim | Vamil Divan | $145 | $123.54 | +0.2% | Jul 13, 2026 |
| HSBC | Rajesh Kumar | $150 | $126.05 | +3.7% | Jul 6, 2026 |
| Jefferies | Analyst unavailable | $141 | $129.38 | -2.6% | Jun 30, 2026 |
| Scotiabank | Analyst unavailable | $155 | $129.38 | +7.1% | Jun 29, 2026 |
| Guggenheim | Vamil Divan | $140 | $115.21 | -3.3% | Jun 2, 2026 |
| Morgan Stanley | Terence Flynn | $112 | $112.47 | -22.6% | May 1, 2026 |
| Wells Fargo | Mohit Bansal | $150 | $116.22 | +3.7% | Mar 12, 2026 |
| RBC Capital | Trung Huynh | $142 | $123.93 | -1.9% | Feb 24, 2026 |
| Deutsche Bank | James Shin | $150 | $121.53 | +3.7% | Feb 13, 2026 |
| Goldman Sachs | Asad Haider | $133 | $115.86 | -8.1% | Feb 4, 2026 |
| BMO Capital | Analyst unavailable | $135 | $115.86 | -6.7% | Feb 4, 2026 |
| Bernstein | Analyst unavailable | $100 | $115.86 | -30.9% | Feb 4, 2026 |
| Scotiabank | Analyst unavailable | $136 | $116.37 | -6.0% | Feb 3, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $116 | $107.4 | -19.8% | Jan 27, 2026 |
| Wolfe Research | Analyst unavailable | $135 | $108.59 | -6.7% | Jan 8, 2026 |
| UBS | Analyst unavailable | $130 | $110.96 | -10.2% | Jan 7, 2026 |
| BMO Capital | Analyst unavailable | $130 | $99.21 | -10.2% | Dec 18, 2025 |
| Morgan Stanley | Analyst unavailable | $102 | $100.06 | -29.5% | Dec 12, 2025 |
| HSBC | Rajesh Kumar | $120 | $96.89 | -17.1% | Dec 10, 2025 |
| Guggenheim | Analyst unavailable | $122 | $100.89 | -15.7% | Dec 5, 2025 |
| Scotiabank | Louise Chen | $120 | $101.88 | -17.1% | Dec 4, 2025 |
| Goldman Sachs | Asad Haider | $120 | $101.83 | -17.1% | Dec 2, 2025 |
| Morgan Stanley | Terence Flynn | $100 | $84.65 | -30.9% | Nov 3, 2025 |
| Berenberg Bank | Luisa Hector | $90 | $81.14 | -37.8% | Sep 17, 2025 |
| Morgan Stanley | Terence Flynn | $98 | $84.39 | -32.3% | Jul 10, 2025 |
| BMO Capital | Evan Seigerman | $82 | $82.74 | -43.3% | Apr 25, 2025 |
| Morgan Stanley | Terence Flynn | $106 | $90.74 | -26.8% | Feb 5, 2025 |
| Bernstein | Courtney Breen | $110 | $100.69 | -24.0% | Dec 2, 2024 |
| Jefferies | Akash Tewari | $148 | $98.36 | +2.3% | Nov 15, 2024 |
| BMO Capital | Evan David Seigerman | $136 | $101.88 | -6.0% | Nov 1, 2024 |
| UBS | Trung Huynh | $136 | $108.88 | -6.0% | Oct 9, 2024 |
| Barclays | Carter Gould | $140 | $109.77 | -3.3% | Oct 7, 2024 |
| Jefferies | Akash Tewari | $147 | $113.49 | +1.6% | Aug 15, 2024 |
| UBS | Colin Bristow | $142 | $112.89 | -1.9% | Jul 31, 2024 |
| Bank of America Securities | Geoff Meacham | $145 | $115.21 | +0.2% | Jul 31, 2024 |
| Wells Fargo | Mohit Bansal | $140 | $131.05 | -3.3% | Jun 12, 2024 |
| BMO Capital | Evan David Seigerman | $148 | $127.71 | +2.3% | May 30, 2024 |
| Truist Financial | Analyst unavailable | $142 | $130.81 | -1.9% | Mar 27, 2024 |
| Jefferies | Akash Tewari | $145 | $130.18 | +0.2% | Mar 27, 2024 |
| Wells Fargo | Mohit Bansal | $135 | $130.19 | -6.7% | Mar 27, 2024 |
| Loop Capital Markets | Evan David Seigerman | $132 | $101.44 | -8.8% | Nov 22, 2023 |
| Oppenheimer | Jay Olson | $147 | $56.34 | +1.6% | Apr 12, 2023 |
| Wells Fargo | Analyst unavailable | $120 | $103.28 | -17.1% | Feb 3, 2023 |
| Morgan Stanley | Analyst unavailable | $99 | $103.46 | -31.6% | Feb 3, 2023 |
| Wells Fargo | Analyst unavailable | $125 | $110.62 | -13.6% | Jan 3, 2023 |
| Cantor Fitzgerald | Analyst unavailable | $135 | $109.2 | -6.7% | Dec 19, 2022 |
| Credit Suisse | Analyst unavailable | $120 | $102.31 | -17.1% | Nov 18, 2022 |
| Leerink Partners | Analyst unavailable | $110 | $86.64 | -24.0% | Sep 30, 2022 |
| Leerink Partners | Analyst unavailable | $109 | $87.34 | -24.7% | Sep 12, 2022 |
| Barclays | Analyst unavailable | $101 | $88.62 | -30.2% | Jul 29, 2022 |
| Morgan Stanley | Analyst unavailable | $92 | $89.26 | -36.4% | Jul 29, 2022 |
| Leerink Partners | Analyst unavailable | $105 | $89.94 | -27.4% | Jul 29, 2022 |
| UBS | Analyst unavailable | $98 | $94.34 | -32.3% | Jul 18, 2022 |
| Atlantic Equities | Analyst unavailable | $110 | $93.6 | -24.0% | Jul 13, 2022 |
| Morgan Stanley | Analyst unavailable | $88 | $93.01 | -39.2% | Jul 8, 2022 |
| Morgan Stanley | Analyst unavailable | $87 | $88.62 | -39.9% | Apr 29, 2022 |
| Leerink Partners | Analyst unavailable | $102 | $88.58 | -29.5% | Apr 29, 2022 |
| Leerink Partners | Analyst unavailable | $97 | $86.46 | -33.0% | Apr 21, 2022 |
| Barclays | Carter Gould | $97 | $86.91 | -33.0% | Apr 16, 2022 |
| Morgan Stanley | Terence Flynn | $80 | $86.63 | -44.7% | Apr 11, 2022 |
| BMO Capital | Evan David Seigerman | $87 | $87.68 | -39.9% | Apr 10, 2022 |
| Goldman Sachs | Chris Shibutani | $93 | $75.02 | -35.7% | Dec 17, 2021 |
| UBS | Colin Bristow | $76 | $72.09 | -47.5% | Dec 13, 2021 |
| Citigroup | Andrew Baum | $85 | $73.53 | -41.3% | Nov 29, 2021 |
| Argus Research | David Toung | $110 | $86.25 | -24.0% | Nov 1, 2021 |
| Barclays | Carter Gould | $94 | $86.25 | -35.0% | Nov 1, 2021 |
| Bank of America Securities | Geoff Meacham | $86 | $86.45 | -40.6% | Oct 29, 2021 |
| Wolfe Research | Tim Anderson | $94 | $86.45 | -35.0% | Oct 29, 2021 |
| RBC Capital | Daniel Busby | $80 | $74.86 | -44.7% | Jul 29, 2021 |
Track every rating change on MRK the moment it posts. Free to start.
Start free